News | March 12, 2015

KLAS Report Finds Siemens Preferred Vendor for Provider Partnership Agreements

The company was recognized as the preferred standard in CT, MR, interventional X-ray and molecular imaging

Siemens, KLAS, preferred vendor, partnership agreements

March 12, 2015 — In a recent survey by the KLAS research firm, Siemens Healthcare was the designated vendor for healthcare providers in 47 percent of current partnership agreements. Moreover, the survey also found that Siemens is the vendor that more executives from the nation’s largest health systems would select over any other company as their first choice for a future partner.

Facing reductions in medical imaging reimbursement, healthcare providers rely increasingly on partnerships with medical imaging equipment manufacturers – which involve the provider using the same vendor across multiple imaging modalities – to help them realize additional sources of value.

Of the 79 surveyed healthcare executives — who represent systems with an average of 2,400 beds — 34 percent identified Siemens as their first-time choice for a partner; that percentage was substantially higher than any other vendor cited in the 2014 KLAS CxO Perceptions Report, entitled “Medical Imaging 2014: Provider Executives Weigh In on Imaging Partnerships.” These healthcare executives also cited Siemens as one of the providers they would be least likely to avoid (14 percent). Additionally, the KLAS report identified Siemens as having the fewest number of dissolved partnerships with healthcare systems.

The surveyed executives praised Siemens’ reliability and cited the company as offering the most innovative medical imaging technology, identifying Siemens as the “preferred standard” in computed tomography (CT), magnetic resonance (MR), interventional X-ray, and molecular imaging.

For more information: www.klasresearch.com

Related Content

Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD)| September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Toshiba Showcases MRI Workflow Enhancements at RSNA 2017
News | Magnetic Resonance Imaging (MRI)| September 21, 2017
September 21, 2017 — Toshiba Medical will highlight its latest...
Hitachi Supria True64 CT Receives FDA Clearance
Technology | Computed Tomography (CT)| September 15, 2017
Hitachi Healthcare Americas Inc. announced it has attained U.S. Food and Drug Administration (FDA) 510(k) clearance to...
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Orange County, Calif. Hospital Adopts Siemens Somatom Force CT for Cardiac Imaging
News | Computed Tomography (CT)| September 12, 2017
Hoag Memorial Hospital Presbyterian recently became the first hospital in Orange County, Calif., to install the Siemens...
Technology | Radiation Dose Management| September 07, 2017
September 7, 2017 — Sapheneia and Scannerside received U.S.
Siemens Healthineers Receives FDA Clearance for TrueFusion Structural Heart Disease Feature
Technology | Cardiovascular Ultrasound| September 06, 2017
The U.S. Food and Drug Administration (FDA) has cleared TrueFusion, a new cardiovascular application from Siemens...
GE Healthcxare Signa Pioneer MAGIC six contrasts in one scan software by SyntheticMR.

The MRI software enables several different contrasts to be obtained from one scan, shortening scan times.

Feature | Magnetic Resonance Imaging (MRI)| August 31, 2017
August 31, 2017 — The U.S. Food and Drug Administration (FDA) has granted market clearance for SyntheticMR’s SyMRI.
European Medicines Agency Issues Update on Gadolinium Contrast Agents
News | Contrast Media| August 29, 2017
August 29, 2017 — The European Medicines Agency (EMA) issued a final opinion that recommended restricting the use of
Overlay Init